DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer

DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer

Abstract Background Duke pancreatic mono-clonal antigen type 2 (DUPAN-II) is a famous tumour maker for pancreatic cancer (PC) as well as carbohydrate antigen 19–9 (CA19-9). We evaluated the clinical implications of DUPAN-II levels as a biological indicator for PC during preoperative chemoradiation t...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Shinichiro Hasegawa, Hidenori Takahashi, Hirofumi Akita, Yosuke Mukai, Manabu Mikamori, Kei Asukai, Daisaku Yamada, Hiroshi Wada, Yoshiaki Fujii, Takahito Sugase, Masaaki Yamamoto, Tomohira Takeoka, Naoki Shinno, Hisashi Hara, Takashi Kanemura, Naotsugu Haraguchi, Junichi Nishimura, Chu Matsuda, Masayoshi Yasui, Takeshi Omori, Hiroshi Miyata, Masayuki Ohue, Osamu Ishikawa, Masato Sakon
स्वरूप: लेख
भाषा:English
प्रकाशित: BMC 2023-01-01
श्रृंखला:BMC Cancer
विषय:
DUPAN-II
Pancreas
Cancer
Preoperative chemoradiation therapy
ऑनलाइन पहुंच:https://doi.org/10.1186/s12885-023-10512-2

इंटरनेट

https://doi.org/10.1186/s12885-023-10512-2

समान संसाधन